Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation
J Domenech, G Cartron, N Clement, et al.
European Journal of Haematology
|
December 2, 1999
Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancy
G Cartron, P Roingeard, L Benboubker, et al.
Journal of Immunological Methods
|
July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serum
H Blasco, G Lalmanach, E Godat, et al.
Leukemia & Lymphoma
|
August 28, 1998
CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases
G Cartron, C Linassier, J L Bremond, et al.
Blood Cancer Journal
|
January 23, 2016
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
A-L Gagez, E Tuaillon, R Cezar, et al.
Blood Cancer Journal
|
August 22, 2015
Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
L Vincent, P Ceballos, C Plassot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2000
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy
C Linassier, C Barin, G Calais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group
E Tchernonog, P Faurie, P Coppo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
April 30, 2002
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation
J Domenech, G Cartron, N Clement, et al.
European Journal of Haematology
|
December 2, 1999
Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancy
G Cartron, P Roingeard, L Benboubker, et al.
Journal of Immunological Methods
|
July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serum
H Blasco, G Lalmanach, E Godat, et al.
Leukemia & Lymphoma
|
August 28, 1998
CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases
G Cartron, C Linassier, J L Bremond, et al.
Blood Cancer Journal
|
January 23, 2016
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
A-L Gagez, E Tuaillon, R Cezar, et al.
Blood Cancer Journal
|
August 22, 2015
Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
L Vincent, P Ceballos, C Plassot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2000
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy
C Linassier, C Barin, G Calais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group
E Tchernonog, P Faurie, P Coppo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
Page
of 4